ArticleRevista da Associacao Medica Brasileira (1992)2026
Evaluation of the use of dienogest in women with deep endometriosis and ovarian endometrioma: a retrospective cohort study.
Article in Revista da Associacao Medica Brasileira (1992), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe aim of this study was to evaluate the use of dienogest in the treatment of deep endometriosis and ovarian endometrioma.
methodsThis retrospective cohort study included 59 women diagnosed with ovarian endometrioma at a tertiary hospital between 2013 and 2018. Pain scores and endometrioma size were evaluated after 12 months of dienogest use, along with the women's sociodemographic characteristics.
resultsThe mean age of the participants was 35.7±6.9 years. Unilateral endometrioma was observed in 38.9% of cases. There was a significant reduction in dysmenorrhea (p=0.011) with dienogest use, but no reduction in other pain symptoms. A reduction in left ovarian volume (p=0.009), mean left endometrioma size (p=0.01), and lesion size in the anterior cul-de-sac (p=0.047) was observed after dienogest treatment. A positive correlation was found between dyschezia and lesions in the posterior cul-de-sac before initiation of dienogest treatment.
conclusionDienogest appears to reduce pain in women with deep endometriosis. Our findings support dienogest as an effective therapeutic option.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.